Establishing biomarkers for COVID-19 that indicate which patients are likely to develop severe disease could help clinicians to categorize patients earlier, improve prognosis and prioritize treatment.
Click here to find out more about Abcam’s SimpleStep ELISA® for blood biomarkers.
With the world facing the most challenging health crisis in a century, we are now entering flu season.
October 29, 2020 More +
High-throughput next-generation sequencing (NGS) technologies continue to provide a wealth of sequence information, resulting in significant advances and new discoveries in a wide range of research areas.
July 02, 2020 More +
Call us on: + 961 1 39 66 77
